BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL

Entity uei:UA43HWRNXFS3 · UEI UA43HWRNXFS3 · parent: BASILEA PHARMACEUTICA AG

About this data

Bounded ingest, not a census: 20,977 contract awards currently loaded (1,294 with full transaction history), per the scope in outlay.config.json. Totals are totals of the ingested set.
Dollar amounts are obligations — money the government has promised to pay, not cash already out the door. Agencies report this data themselves; the Defense Department publishes ~90 days late; the current budget year is still in progress. See methodology.
Source records republish silently; Outlay keeps its own append-only version archive from first pull onward. Post-publication revisions recorded so far: 0 awards (0 revisions). Revisions are routine (spending progresses, errors get corrected) and are not themselves evidence of anything.

Last ingest run #11 (failed) started Aug 5, 2026, 07:42 UTC — 0 awards, 0 details, 0 transactions.

Obligations by fiscal year

$122.5M


75A50124C00033 ↗ THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA	Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	FY2024	Sep 30, 2024 – Mar 31, 2032	$122.5M	$252.1M	2

Raw recipient names from source records that resolved to this entity.